Main Banners LinkedIn Facebook Twitter Youtube Instagram
  • Home
  • Key Information
  • Program
  • Posters
  • Speakers
  • Attendees
  • Exhibitors
  • Sponsors

Filter By
First Name Last Name Company Position State Country Updated
List Print
user-icon
Cat Davis Ahmed

Vice President, Policy and Outreach at The FH Foundation

Pasadena CA UNITED STATES

  • Program
    • IP10: PRIOR AUTHORIZATION POLICIES FOR MANAGING SPECIALTY DRUG SPENDING IN THE UNITED STATES: CAN WE STRIKE A BALANCE BETWEEN APPROPRIATE UTILIZATION AND APPROPRIATE ACCESS?
Request Meeting Message
0_07OU4rI0-9bFTVSemWiYdAcVh9oI5ZCwIQGgWmIMKQRSqN3IeYGZZEwM3EbI5VSemji4JBoptxIw9W3wDX7qfIExLxII9WreeX7Msrn0K5sG9OT3e8xZyTfr21
Amine Aissaoui

Researcher at Paris Dauphine University, PSL

Paris FRANCE

  • Program
    • W7: ARTIFICIAL INTELLIGENCE AND PRECISION MEDICINE: DOES THE HEALTH ECONOMIST NEED TO ADAPT TO THE MACHINE?
Request Meeting Message
Alfonso_Rafael
Rafael Alfonso-Cristancho

Senior Director at GSK Consumer Care

Collegeville PA UNITED STATES

  • Program
    • IP21: IS ARTIFICIAL INTELLIGENCE THE NEXT BIG THING IN HEALTHCARE DECISION MAKING?
Request Meeting Message
0
Omar Ali

Pharmacy Director at NICE

London UNITED KINGDOM

  • Program
    • W17: DO CUTTING-EDGE ONE-TIME TREATMENTS NEED EQUALLY INNOVATIVE-, OUTCOMES-, OR ANNUITY-BASED PAYMENT MODELS?
Request Meeting Message
Ambegaonkar_Ambarish
Ambarish J. Ambegaonkar

Founder and Managing Partner at APPERTURE LLC

Marlboro NJ UNITED STATES

  • Program
    • Economic and Financial Drivers of Value Focus and Development of a Holistic Value Proposition
Request Meeting Message
Augustovski_Federico_2016
Federico Augustovski

Director, HTA at (IECS) Institute for Clinical Effectiveness and Health Policy

Buenos Aires ARGENTINA

  • Program
    • INCOMING PRESIDENTIAL ADDRESS
Request Meeting Message
Barsdorf_Alexandra
Alexandra Barsdorf

Director, Outcomes & Evidence at Pfizer, Inc

New York NY UNITED STATES

  • Program
    • Introduction to Patient Reported Outcomes
Request Meeting Message
Anirban_Basu
Dr Anirban Basu

Stergachis Family Endowed Professor & Director at University of Washington

Seattle WA UNITED STATES

  • Program
    • F6: VALUE OF INFORMATION (VOI) ANALYSIS FOR RESEARCH DECISIONS EMERGING GOOD PRACTICES TASK FORCE: FINAL RECOMMENDATIONS
Request Meeting Message
user-icon
Katy Benjamin

Director at AbbVie Inc

Chicago IL UNITED STATES

  • Program
    • IP23: ESTIMATING SAMPLE SIZE FOR QUALITATIVE RESEARCH IN CLINICAL OUTCOME ASSESSMENT RESEARCH: ONE SIZE DOES NOT FIT ALL!
Request Meeting Message
user-icon
Nancy Berg

Request Meeting Message
user-icon
Marc Berger

Consultant at Self Employed

New York NY UNITED STATES

  • Program
    • EDUCATIONAL SYMPOSIUM: DEBATING THE FUTURE OF HEALTHCARE
    • IP16: IN THE ELECTRONIC HEALTH RECORD ERA, DO WE STILL NEED CLINICAL REGISTRIES?
Request Meeting Message
user-icon
Jasmine Bihm

Staff Fellow at Agency for Healthcare Research and Quality (AHRQ)

Rockville MD UNITED STATES

  • Program
    • W3: DIGITAL HEALTH: EVALUATING THE EVIDENCE, IDENTIFYING GAPS, PRODUCING BETTER SCIENCE
Request Meeting Message
JBB_shot2
Jakob Bjorner

Chief Science Officer at Optum Patients Insights

Johnston RI UNITED STATES

  • Program
    • W20: FIXING THE TOWER OF BABEL: ESTABLISHING A COMMON METRIC FOR PATIENT-REPORTED OUTCOME MEASURES
Request Meeting Message
user-icon
Kathleen Blake

Vice President, Healthcare Quality at American Medical Association (AMA)

Washington DC UNITED STATES

  • Program
    • IP7: THE CHANGING LANDSCAPE OF HEALTHCARE DECISION MAKING: HOW CAN WE LEVERAGE THE USE OF REAL-WORLD EVIDENCE FOR REGULATORY, COVERAGE, AND CLINICAL DECISION MAKING?
Request Meeting Message
user-icon
Michael Blum

Deputy Director at U.S. Food & Drug Administration

Silver Spring MD UNITED STATES

  • Program
    • W4: BIOSIMILARS, UTILIZATION, AND POST-MARKETING SURVEILLANCE IN THE UNITED STATES (Invited Workshop)
Request Meeting Message
Brazier_John
John Brazier

Dean at University of Sheffield

Sheffield UNITED KINGDOM

  • Program
    • Utility Measures
    • F1: HEALTH STATE UTILITY (HSU) GOOD PRACTICES TASK FORCE RECOMMENDATIONS FOR IDENTIFICATION AND USE OF HSU DATA IN COST-EFFECTIVENESS IN DECISION MODELLING
    • P15: UTILITY AND PATIENT PREFERENCE STUDIES
Request Meeting Message
Briggs-Andrew
Andrew Briggs

Professor of Health Economics at Health Economics and Health Technology Assessment, University of Glasgow

Glasgow UNITED KINGDOM

  • Program
    • Collecting Health-State Utility Estimates for Economic Models in Clinical Studies
    • Advanced Decision Modeling for Health Economic Evaluations
    • IP3: THE MACHINE LEARNING DEBATE: PANACEA OR THE NEW ALCHEMY?
    • P9: HEALTH TECHNOLOGY ASSESSMENT STUDIES
Request Meeting Message
Brixner_Diana
Diana Brixner

Professor, Department of Pharmacotherapy, University of Utah College of Pharmacy at University of Utah

Salt Lake City UT UNITED STATES

  • Program
    • Applications in Using Large Databases
    • EDUCATIONAL SYMPOSIUM: HEALTHCARE GRIDLOCK BETWEEN VALUE, AFFORDABILITY, AND ACCESS: THE GOOD, THE BAD AND THE UGLY
Request Meeting Message
Brodtkorb-Thor-Henrik
Thor-Henrik Brodtkorb

Senior Director, Health Economics at RTI Health Solutions

Ljungskile SWEDEN

  • Program
    • Budget Impact Analysis II – Applications and Design Issues
Request Meeting Message
brogan_anita
Anita Brogan

Head at RTI Health Solutions

Manchester UNITED KINGDOM

  • Program
    • Budget Impact Analysis II – Applications and Design Issues
Request Meeting Message
  • 1
  • 2
  • 3
  • ..
  • 9
  • »
Event App Powered By Zerista. Copyright 2018. Privacy Support